ZTS FY 2014 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$53B

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.8B+4.9% YoY

Gross Profit

$3.0B62.9% margin

Operating Income

$970M20.3% margin

Net Income

$583M12.2% margin

EPS (Diluted)

$1.16

Cash Flow

Operating Cash Flow

$626M

Free Cash Flow

$431M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$6.6B

Total Liabilities

$5.3B

Stockholders' Equity

$1.3B

Cash & Equivalents

$882M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.8B	$4.6B	+4.9%
Gross Profit	$3.0B	$2.8B	+6.2%
Operating Income	$970M	$821M	+18.1%
Net Income	$583M	$504M	+15.7%